Huda Zahid

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Photodynamic Therapy

Single Molecule

Gold Nanoparticles

Top Venues

Journal of medicinal chemistry

ACS chemical biology

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Huda Zahid, Jeff P Costello, Yao Li, Jennifer R Kimbrough, Marisa Actis, Zoran Rankovic, Qin Yan, William C K Pomerantz
Design of Class I/IV Bromodomain-Targeting Degraders for Chromatin Remodeling Complexes. ACS chemical biology (2023)
Prakriti Kalra, Huda Zahid, Alex Ayoub, Nils O Lindström, William C K Pomerantz
Alternative Mechanisms for DNA Engagement by BET Bromodomain-Containing Proteins. Biochemistry 61 (13) (2022)
Huarui Cui, Anand Divakaran, Zachariah J Hoell, Mikael O Ellingson, Cole R Scholtz, Huda Zahid, Jorden A Johnson, Elizabeth C Griffith, Clifford T Gee, Amani L Lee, Shalil Khanal, Ke Shi, Hideki Aihara, Vijay H Shah, Richard E Lee, Daniel A Harki, William C K Pomerantz
A Structure-based Design Approach for Generating High Affinity BRD4 D1-Selective Chemical Probes. Journal of medicinal chemistry 65 (3) (2022)
Anand Divakaran, Cole R Scholtz, Huda Zahid, Wenwei Lin, Elizabeth C Griffith, Richard E Lee, Taosheng Chen, Daniel A Harki, William C K Pomerantz
Development of an N-Terminal BRD4 Bromodomain-Targeted Degrader. ACS medicinal chemistry letters 13 (10) (2022)
Huda Zahid, Caroline R Buchholz, Manjulata Singh, Michael F Ciccone, Alice Chan, Stanley Nithianantham, Ke Shi, Hideki Aihara, Marcus Fischer, Ernst K Schonbrunn, Camila O Dos Santos, Joseph W Landry, William C K Pomerantz
New Design Rules for Developing Potent Cell-Active Inhibitors of the Nucleosome Remodeling Factor (NURF) via BPTF Bromodomain Inhibition. Journal of medicinal chemistry 64 (18) (2021)